Zobrazeno 1 - 10
of 227
pro vyhledávání: '"Jaap C, Reijneveld"'
Autor:
Ivan Caramanna, Jaap C. Reijneveld, Peter M. van de Ven, Martin van den Bent, Ahmed Idbaih, Wolfgang Wick, Martin J.B. Taphoorn, Linda Dirven, Andrew Bottomley, Martin Klein
Publikováno v:
European Journal of Cancer, 186, 38-51. Elsevier Ltd.
European Journal of Cancer, 186, 38-51. Pergamon
Caramanna, I, Reijneveld, J C, van de Ven, P M, van den Bent, M, Idbaih, A, Wick, W, Taphoorn, M J B, Dirven, L, Bottomley, A & Klein, M 2023, ' Association between objective neurocognitive functioning and neurocognitive complaints in recurrent high-grade glioma : Longitudinal evidence of cognitive awareness from EORTC brain tumour trials ', European Journal of Cancer, vol. 186, pp. 38-51 . https://doi.org/10.1016/j.ejca.2023.02.029
European Journal of Cancer, 186, 38-51. Pergamon
Caramanna, I, Reijneveld, J C, van de Ven, P M, van den Bent, M, Idbaih, A, Wick, W, Taphoorn, M J B, Dirven, L, Bottomley, A & Klein, M 2023, ' Association between objective neurocognitive functioning and neurocognitive complaints in recurrent high-grade glioma : Longitudinal evidence of cognitive awareness from EORTC brain tumour trials ', European Journal of Cancer, vol. 186, pp. 38-51 . https://doi.org/10.1016/j.ejca.2023.02.029
Background: Patients’ reduced awareness of neurocognitive functioning (NCF) may negatively affect the reliability of patient-reported outcomes (PROs) and clinical decision-making. This study evaluated cognitive awareness, defined as the association
Autor:
Anouk S. Schuit, Karen Holtmaat, Nienke Hooghiemstra, Femke Jansen, Birgit I. Lissenberg-Witte, Veerle M. H. Coupé, Myra E. van Linde, Annemarie Becker-Commissaris, Jaap C. Reijneveld, Josée M. Zijlstra, Dirkje W. Sommeijer, Simone E. J. Eerenstein, Irma M. Verdonck-de Leeuw
Publikováno v:
BMC Palliative Care, Vol 18, Iss 1, Pp 1-11 (2019)
Abstract Background Patients with incurable cancer have to deal with a wide range of symptoms due to their disease and treatment, influencing their quality of life. Nowadays, patients are expected to adopt an active role in managing their own health
Externí odkaz:
https://doaj.org/article/5c0f8a526bd3456298b2d57e3b5a0a4c
Autor:
Niels Verburg, Thomas Koopman, Maqsood Yaqub, Otto S. Hoekstra, Adriaan A. Lammertsma, Lothar A. Schwarte, Frederik Barkhof, Petra J. W. Pouwels, Jan J. Heimans, Jaap C. Reijneveld, Annemieke J. M. Rozemuller, William P. Vandertop, Pieter Wesseling, Ronald Boellaard, Philip C. de Witt Hamer
Publikováno v:
EJNMMI Research, Vol 9, Iss 1, Pp 1-9 (2019)
Abstract Background Positron emission tomography (PET) is increasingly used to guide local treatment in glioma. The purpose of this study was a direct comparison of two potential tracers for detecting glioma infiltration, O-(2-[18F]-fluoroethyl)-l-ty
Externí odkaz:
https://doaj.org/article/6d9c6a5bb9024f70a10e92b69f8c0b8e
Autor:
Limin Liu, Jungyeon Choi, Jammbe Z Musoro, Willi Sauerbrei, Cecilie Delphin Amdal, Ahu Alanya, Yolanda Barbachano, Joseph C Cappelleri, Ragnhild Sørum Falk, Mallorie H Fiero, Antoine Regnault, Jaap C Reijneveld, Rickard Sandin, Doranne Thomassen, Satrajit Roychoudhury, Els Goetghebeur, Saskia le Cessie, Olalekan Lee Aiyegbusi, Ethan Basch, Melanie Calvert, Alicyn Campbell, Joseph Cappelleri, Samantha Cruz Rivera, Mallorie Fiero, Rajesh Kamalakar, Karen Keating, Paul Kluetz, Geert Molenberghs, Jammbe Musoro, David Ness, Khadija Rantell, Jaap Reijneveld, Gerhard Rumpold, Alexander Russell-Smith, Claudia Rutherford, Kavita Sail, Maxime Sasseville, Anja Schiel, Michael Schlichting, Kathy Soltys, Ragnhild Sorum Falk, Yun Su, Silene ten Seldam, Kelly Van Lancker
Publikováno v:
Liu, L, Choi, J, Musoro, J Z, Sauerbrei, W, Amdal, C D, Alanya, A, Barbachano, Y, Cappelleri, J C, Falk, R S R, Fiero, M H, Regnault, A, Reijneveld, J C, SISAQOL-IMI Work Package 3, Sandin, R, Thomassen, D, Roychoudhury, S, Goetghebeur, E & le Cessie, S 2023, ' Single-arm studies involving patient-reported outcome data in oncology : a literature review on current practice ', The Lancet Oncology, vol. 24, no. 5, pp. e197-e206 . https://doi.org/10.1016/S1470-2045(23)00110-9
Patient-reported outcomes (PROs) are increasingly used in single-arm cancer studies. We reviewed 60 papers published between 2018 and 2021 of single-arm studies of cancer treatment with PRO data for current practice on design, analysis, reporting, an
Autor:
Florien W Boele, Patricia W M den Otter, Jaap C Reijneveld, Philip C de Witt Hamer, Hinke F van Thuijl, Linda M C Lorenz, Pieter Wesseling, Frank J Lagerwaard, Martin J B Taphoorn, Mathilde C M Kouwenhoven, Tom J Snijders, Linda Douw, Martin Klein
Publikováno v:
Neuro-Oncology, 25(2), 351-364. Oxford University Press
Neuro-Oncology, 25(2), 351-364. OXFORD UNIV PRESS INC
Boele, F W, den Otter, P W M, Reijneveld, J C, de Witt Hamer, P C, van Thuijl, H F, Lorenz, L M C, Wesseling, P, Lagerwaard, F J, Taphoorn, M J B, Kouwenhoven, M C M, Snijders, T J, Douw, L & Klein, M 2023, ' Long-term wellbeing and neurocognitive functioning of diffuse low-grade glioma patients and their caregivers : A longitudinal study spanning two decades ', Neuro-Oncology, vol. 25, no. 2, pp. 351-364 . https://doi.org/10.1093/neuonc/noac185, https://doi.org/10.1093/neuonc/noac185
Neuro-Oncology, 25(2), 351-364. OXFORD UNIV PRESS INC
Boele, F W, den Otter, P W M, Reijneveld, J C, de Witt Hamer, P C, van Thuijl, H F, Lorenz, L M C, Wesseling, P, Lagerwaard, F J, Taphoorn, M J B, Kouwenhoven, M C M, Snijders, T J, Douw, L & Klein, M 2023, ' Long-term wellbeing and neurocognitive functioning of diffuse low-grade glioma patients and their caregivers : A longitudinal study spanning two decades ', Neuro-Oncology, vol. 25, no. 2, pp. 351-364 . https://doi.org/10.1093/neuonc/noac185, https://doi.org/10.1093/neuonc/noac185
Background While patients with diffuse low-grade glioma (LGG) often survive for years, there is a risk of tumor progression which may impact patients’ long-term health-related quality of life (HRQOL) and neurocognitive functioning (NCF). We present
Autor:
Claire Piccinin, Ethan Basch, Vishal Bhatnagar, Melanie Calvert, Alicyn Campbell, David Cella, Charles S Cleeland, Corneel Coens, Anne-Sophie Darlington, Amylou C Dueck, Mogens Groenvold, Ralf Herold, Bellinda L King-Kallimanis, Paul G Kluetz, Dagmara Kuliś, Daniel O'Connor, Kathy Oliver, Madeline Pe, Bryce B Reeve, Jaap C Reijneveld, Xin Shelley Wang, Andrew Bottomley
Publikováno v:
Piccinin, C, Basch, E, Bhatnagar, V, Calvert, M, Campbell, A, Cella, D, Cleeland, C S, Coens, C, Darlington, A-S, Dueck, A C, Groenvold, M, Herold, R, King-Kallimanis, B L, Kluetz, P G, Kuliś, D, O'Connor, D, Oliver, K, Pe, M, Reeve, B B, Reijneveld, J C, Wang, X S & Bottomley, A 2023, ' Recommendations on the use of item libraries for patient-reported outcome measurement in oncology trials : findings from an international, multidisciplinary working group ', Lancet Oncology, vol. 24, no. 2, pp. e86-e95 . https://doi.org/10.1016/S1470-2045(22)00654-4
The use of item libraries for patient-reported outcome (PRO) measurement in oncology allows for the customisation of PRO assessment to measure key health-related quality of life concepts of relevance to the target population and intervention. However
Autor:
Nik Sol, Sjors G.J.G. in ‘t Veld, Adrienne Vancura, Maud Tjerkstra, Cyra Leurs, François Rustenburg, Pepijn Schellen, Heleen Verschueren, Edward Post, Kenn Zwaan, Jip Ramaker, Laurine E. Wedekind, Jihane Tannous, Bauke Ylstra, Joep Killestein, Farrah Mateen, Sander Idema, Philip C. de Witt Hamer, Anna C. Navis, William P.J. Leenders, Ann Hoeben, Bastiaan Moraal, David P. Noske, W. Peter Vandertop, R. Jonas A. Nilsson, Bakhos A. Tannous, Pieter Wesseling, Jaap C. Reijneveld, Myron G. Best, Thomas Wurdinger
Publikováno v:
Cell Reports Medicine, Vol 1, Iss 7, Pp 100101- (2020)
Summary: Tumor-educated platelets (TEPs) are potential biomarkers for cancer diagnostics. We employ TEP-derived RNA panels, determined by swarm intelligence, to detect and monitor glioblastoma. We assessed specificity by comparing the spliced RNA pro
Externí odkaz:
https://doaj.org/article/3c63ceb85e20460e8535824c45ce6bd6
Autor:
Marieke van Leeuwen, Olga Husson, Paola Alberti, Juan Ignacio Arraras, Olivier L. Chinot, Anna Costantini, Anne-Sophie Darlington, Linda Dirven, Martin Eichler, Eva B. Hammerlid, Bernhard Holzner, Colin D. Johnson, Meropi Kontogianni, Trille Kristina Kjær, Ofir Morag, Sandra Nolte, Andrew Nordin, Andrea Pace, Monica Pinto, Katja Polz, John Ramage, Jaap C. Reijneveld, Samantha Serpentini, Krzysztof A. Tomaszewski, Vassilios Vassiliou, Irma M. Verdonck-de Leeuw, Ingvild Vistad, Teresa E. Young, Neil K. Aaronson, Lonneke V. van de Poll-Franse, on behalf of the EORTC QLG
Publikováno v:
Health and Quality of Life Outcomes, Vol 16, Iss 1, Pp 1-15 (2018)
Abstract Backround The number of cancer survivors is growing steadily and increasingly, clinical trials are being designed to include long-term follow-up to assess not only survival, but also late effects and health-related quality of life (HRQOL). T
Externí odkaz:
https://doaj.org/article/bd2fa22b0abd4936aac49f46b734934a
Autor:
Jolanda Derks, Anne R. Dirkson, Philip C. de Witt Hamer, Quinten van Geest, Hanneke E. Hulst, Frederik Barkhof, Petra J.W. Pouwels, Jeroen J.G. Geurts, Jaap C. Reijneveld, Linda Douw
Publikováno v:
NeuroImage: Clinical, Vol 14, Iss C, Pp 87-96 (2017)
Gliomas are primary brain tumors, originating from the glial cells in the brain. In contrast to the more traditional view of glioma as a localized disease, it is becoming clear that global brain functioning is impacted, even with respect to functiona
Externí odkaz:
https://doaj.org/article/5fd77e22d0e543c4b5b7dd39354d7afc
Autor:
Ivan Caramanna, Julie M de Kort, Alba A Brandes, Walter Taal, Michael Platten, Ahmed Idbaih, Jean Sebastien Frenel, Wolfgang Wick, Chandrakanth Jayachandran Preetha, Martin Bendszus, Philipp Vollmuth, Jaap C Reijneveld, Martin Klein
Publikováno v:
Neuro-Oncology Practice, 9(4), 310-316. Oxford University Press
Caramanna, I, de Kort, J M, Brandes, A A, Taal, W, Platten, M, Idbaih, A, Frenel, J S, Wick, W, Preetha, C J, Bendszus, M, Vollmuth, P, Reijneveld, J C & Klein, M 2022, ' Corticosteroids use and neurocognitive functioning in patients with recurrent glioblastoma : Evidence from European Organization for Research and Treatment of Cancer (EORTC) trial 26101 ', Neuro-Oncology Practice, vol. 9, no. 4, pp. 310-316 . https://doi.org/10.1093/nop/npac022
Caramanna, I, de Kort, J M, Brandes, A A, Taal, W, Platten, M, Idbaih, A, Frenel, J S, Wick, W, Preetha, C J, Bendszus, M, Vollmuth, P, Reijneveld, J C & Klein, M 2022, ' Corticosteroids use and neurocognitive functioning in patients with recurrent glioblastoma : Evidence from European Organization for Research and Treatment of Cancer (EORTC) trial 26101 ', Neuro-Oncology Practice, vol. 9, no. 4, pp. 310-316 . https://doi.org/10.1093/nop/npac022
Background In patients with recurrent glioblastoma, corticosteroids are frequently used to mitigate intracranial pressure and to improve patient neurological functioning. To date, in these patients, no systematic studies have been performed to assess